Clinical Trial Update: HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining HLA-mismatched microtransplantation for high-risk acute myeloid leukemia; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• HLA-mismatched microtransplantation

Snippet

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: UNKNOWN